Skip to main content
. Author manuscript; available in PMC: 2019 Dec 15.
Published in final edited form as: Cancer. 2018 Nov 13;124(24):4657–4666. doi: 10.1002/cncr.31761

Figure 5: Entinostat (ENT) does not significantly inhibit tumor growth or increase MHCII or PDL1 expression in Rag1 knockout mice.

Figure 5:

A) In Rag1 knockout mice, there was no difference in omental tumor weight between mice treated with ENT versus vehicle control (54.3 vs. 79.8 mg, p=0.093) and no difference in ascites formation. B) There was no difference in either MHCII (1,250.0 vs. 1,483.0 MFI, p=0.152) or PDL1 expression (805.8 vs. 706.0 MFI, p=0.258) in Rag1 knockout mice treated with ENT versus vehicle control. n=6 mice per group.